OPKO Health, Inc. (NASDAQ:OPK) marched up 3.64% compared to a 52-week low price of $2.34. The shares were last seen trading -5.1% lower, taking the closing price at $2.42 on 3/14/2019. At a recent session, the prices were hovering between $2.4 and $2.57. This company shares are 106.61% off its target price of $5 and the current market capitalization stands at $1.53B. The recent change has given its price a -23.11% deficit over SMA 50 and -62.19% deficit over its 52-week high. The stock witnessed -14.49% declines, -27.33% declines and -58.28% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found OPK’s volatility during a week at 4.59% and during a month it has been found around 4.65%.

OPKO Health, Inc. (OPK) Top Holders

Institutional investors currently hold around $364 million or 23.6% in OPK stock. Look at its top three institutional owners: Blackrock Inc. owns $77.21 million in OPKO Health, Inc., which represents roughly 5.05% of the company’s market cap and approximately 21.21% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 28,381,653 shares of the stock are valued at $72.37 million. The third largest holder is State Street Corp, which currently holds $39.89 million worth of this stock and that ownership represents nearly 2.61% of its market capitalization.

OPKO Health, Inc. 13F Filings

At the end of December reporting period, 89 institutional holders increased their position in OPKO Health, Inc. (NASDAQ:OPK) by some 10,729,969 shares, 103 decreased positions by 19,597,240 and 45 held positions by 112,276,499. That puts total institutional holdings at 142,603,708 shares, according to SEC filings. The stock grabbed 37 new institutional investments totaling 2,850,226 shares while 37 institutional investors sold out their entire positions totaling 2,236,700 shares.

OPKO Health, Inc. (OPK) Analyst Guide

Several analysts have released their opinion on OPKO Health, Inc. (NASDAQ:OPK), with 0 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.33 average brokerage recommendation [T1].